EP2332575
Treatment of cancer with novel anti-IL 13 monoclonal antibodies
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
23.12.2004EP published:
12.11.2014EP application number:
10179775.1
EPO information:
European Patent Register
Max expiry date:
22.12.2024
Title:
Treatment of cancer with novel anti-IL 13 monoclonal antibodies
Timeline
Today
23.12.2004EP application
12.11.2014EP Publication
Owner
Name:
Genentech, Inc.Address:
1 DNA Way, 94080, South San Francisco, CA, US
Inventor
Name:
Fung, Sek ChungAddress:
Gaithersburg, MD, US
Name:
Moyle, MatthewAddress:
Redmond, WA, US
Priority
Number:
532130 PDate:
23.12.2003Country:
US
Classification
Categories:
A61K 39/395, A61P 35/00, G01N 33/53, C07K 16/24